Welcome to E-Menai

ambien be taken with alcohol Established in 1894, Kowa is actively engaged in various manufacturing and trading activities in the fields of pharmaceutical, life science, information technology, textiles, machinery and various consumer products. Its lead product, LIPOFEN® (fenofibrate capsules), is indicated as adjunctive therapy to diet to reduce elevated triglycerides and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia. R&D activities are carried out directly or under contract. For more information about APR, please visit www. Acura Pharmaceuticals, Inc.